Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 155 SEK 2.58% Market Closed
Market Cap: 12.3B SEK
Have any thoughts about
Biotage AB?
Write Note

Wall Street
Price Targets

BIOT Price Targets Summary
Biotage AB

Wall Street analysts forecast BIOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOT is 225.17 SEK with a low forecast of 197.96 SEK and a high forecast of 288.75 SEK.

Lowest
Price Target
197.96 SEK
28% Upside
Average
Price Target
225.17 SEK
45% Upside
Highest
Price Target
288.75 SEK
86% Upside
Biotage AB Competitors:
Price Targets
688315
Novogene Co Ltd
50% Upside
MXCT
MaxCyte Inc
149% Upside
LAB
Standard BioTools Inc
97% Upside
RVU
Ryvu Therapeutics SA
81% Upside
WAT
Waters Corp
3% Upside
688046
GemPharmatech Co Ltd
42% Upside
TKNO
Alpha Teknova Inc
11% Upside
VIMTALABS
Vimta Labs Ltd
22% Downside

Revenue
Forecast

Revenue Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 15%.

15%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 21%. The projected CAGR for the next 3 years is 28%.

21%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's net income is 16%. The projected CAGR for the next 3 years is 32%.

16%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOT's stock price target?
Price Target
225.17 SEK

According to Wall Street analysts, the average 1-year price target for BIOT is 225.17 SEK with a low forecast of 197.96 SEK and a high forecast of 288.75 SEK.

What is Biotage AB's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 15%.

What is Biotage AB's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 21%. The projected CAGR for the next 3 years is 28%.

What is Biotage AB's Net Income forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for Biotage AB's net income is 16%. The projected CAGR for the next 3 years is 32%.

Back to Top